FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 Erectile Dysfunction: Exploring the Peptide's Potential Role